Hematology - European Medical Journal
×

Browse

Hematology

articles
12
Dec

Anticipate Your Next Move in Chronic Myeloid Leukaemia Patient Management
Hematology
19
Sep

Improving Patient Outcomes in Acute Leukaemias: Navigating Complex Treatment Decisions in an Era of Novel Therapies
Hematology
This symposium took place on 14th June 2019, as part of the 24th European Hematology Association (EHA) Annual Congress in Amsterdam, Netherlands
12
Sep

Variability of Biologics and its Impact on Biosimilar Development
Hematology
The World Health Organization (WHO) states that access to essential medicines is part of the right to health…
01
Aug

Rebooting the Myeloma Treatment Programme
Hematology
Treatment of MM requires a multifaceted approach using a combination of therapies targeting the several pathophysiological pathways involved in the disease…
01
Aug

Umbilical Cord Blood Donation: An Evolving Lifeline for the Stem Cell Field
Hematology
The fact that stem cells hold increasingly apparent and still untapped potential for the treatment of a multitude of genetic diseases is undisputed…
01
Aug

Editor’s Pick: New Insights in β-Thalassaemia
Hematology
Thalassaemia is a hereditary cause of hypochromic microcytic anaemia resulting from defects in haemoglobin (Hb) production…
01
Aug

Retrospective Review of the Role of Abdominal Imaging in Evaluation of Cytopenias
Hematology
Normal blood cell count is defined by normal values in all three major haematopoietic cell lineages (i.e., leukocytes, haemoglobin, and platelets) plus…
01
Aug

Eltrombopag-Induced Myelofibrosis in Patients with Adult Immune Thrombocytopenia: Scoping Review
Hematology
Immune thrombocytopenia (ITP) is an autoimmune bleeding disorder that lessens the production of platelets. Despite treatments being available for ITP…
01
Aug

Resistant Bilateral Chylous Effusion as a Late Adverse Effect of Dasatinib Treatment in Chronic Myeloid Leukaemia
Hematology
Dasatinib is a potent and efficacious second-generation oral tyrosine kinase inhibitor, frequently used for imatinib-resistant or intolerant BCR-ABL+…
01
Aug

Are Successful Pregnancies an Achievable Goal in Patients with Chronic Myeloid Leukaemia?
Hematology
BCR-ABL1 positive chronic myeloid leukaemia (CML) is a myeloproliferative neoplasm in which granulocytes are the major proliferative component. BCR-ABL1…
01
Aug

A Review of the Different Haematological Parameters and Biomarkers Used for Diagnosis of Neonatal Sepsis
Hematology
Neonatal sepsis has been a leading cause of high morbidity and mortality in newborns and is recognised as a global health challenge.1-3 The definition…
08
Apr

Expectations and Experience: Optimising Efficacy and Maintaining Quality of Life in Follicular Lymphoma
Hematology
Prof Salles provided an update on the ongoing first-line follicular lymphoma (FL) studies, demonstrating how analysis of the GALLIUM study data regarding…
13
Dec

Editor’s Pick: Newest Approaches in Immunotherapy for Non-Hodgkin’s Lymphoma
Hematology
Immunotherapy has revolutionised the treatment of haematologic malignancies. Patients with relapsed/refractory non-Hodgkin’s lymphoma have poor response…
04
Sep

Editor’s Pick: Chimeric Antigen Receptor-Engineered T Cell Therapy in Acute Myeloid Leukaemia
Hematology
Acute myeloid leukaemia (AML) is a disease with a very poor outcome and remains an area of significant unmet need, necessitating novel therapeutic…
04
Sep

Epstein–Barr Virus: A Biological Overview and Clinicopathological Changes of Two Epstein–Barr Virus-Related Lymphoproliferative Disorders in a World Health Organization (WHO) 2017 Report
Hematology
Epstein–Barr virus (EBV) is one of the most important viral causes for the development of tumours. The global geographical epidemiology of EBV shows…
04
Sep

A Game of Clones: The Complex Interplay of Aplastic Anaemia, Myelodysplastic Syndrome, and Paroxysmal Nocturnal Haemoglobinuria
Hematology
Although idiopathic aplastic anaemia (AA), myelodysplastic syndrome (MDS), and paroxysmal nocturnal haemoglobinuria (PNH) are all associated with…